C1QTNF1
Complement C1q tumor necrosis factor-related protein 1
Also known as: C1QT1_HUMAN, CTRP1, FLJ90694, GIP, ZSIG37
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9BXJ1
- Gene
- C1QTNF1
- Ensembl
- ENSG00000173918
- Chromosome
- 17
- Canonical length
- 281 aa
- Protein class
- Predicted intracellular proteins, Predicted secreted proteins
- Subcellular location
- Nucleoplasm,Cytosol
- Secretome location
- Secreted to blood
OverviewNCBI Gene
Enables collagen binding activity. Involved in several processes, including negative regulation of platelet aggregation; positive regulation of aldosterone secretion; and positive regulation of cytosolic calcium ion concentration. Located in extracellular space and plasma membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
281 residues, UniProt reviewed canonical sequence.
>Q9BXJ1|C1QTNF1
1 MGSRGQGLLL AYCLLLAFAS GLVLSRVPHV QGEQQEWEGT EELPSPPDHA ERAEEQHEKY
61 RPSQDQGLPA SRCLRCCDPG TSMYPATAVP QINITILKGE KGDRGDRGLQ GKYGKTGSAG
121 ARGHTGPKGQ KGSMGAPGER CKSHYAAFSV GRKKPMHSNH YYQTVIFDTE FVNLYDHFNM
181 FTGKFYCYVP GLYFFSLNVH TWNQKETYLH IMKNEEEVVI LFAQVGDRSI MQSQSLMLEL
241 REQDQVWVRL YKGERENAIF SEELDTYITF SGYLVKHATE PLocalizationUniProt · AlphaFold · HPA
Whether an antibody against C1QTNF1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.52
- Highest tissue expression
- 293 nTPM
Expression across tissuesHPA
Tissue
- blood vessel: 293 nTPM
- heart muscle: 271 nTPM
- adipose tissue: 174 nTPM
- breast: 132 nTPM
- thyroid gland: 95 nTPM
- adrenal gland: 64 nTPM
Single-cell type
- vascular smooth muscle cells: 272 nCPM
- hepatic stellate cells: 155 nCPM
- pericytes: 155 nCPM
- breast lactating cells: 115 nCPM
- epicardial cells: 105 nCPM
- syncytiotrophoblasts: 69 nCPM
Immune cell
- basophil: 0.3 nTPM
- NK-cell: 0.1 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- choroid plexus: 91 nTPM
- midbrain: 47 nTPM
- thalamus: 40 nTPM
- medulla oblongata: 33 nTPM
- hypothalamus: 33 nTPM
- pons: 32 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.09
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.53
- DepMap mean gene effect
- -0.16
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- negative regulation of platelet activation
- negative regulation of platelet aggregation
- positive regulation of aldosterone secretion
- positive regulation of cytosolic calcium ion concentration
- positive regulation of gene expression
- positive regulation of MAPK cascade
- positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction
- regulation of glucose metabolic process
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of C1QTNF1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads C1QTNF1 as an antibody target. Whether an autoantibody or antibody against C1QTNF1 could matter depends on whether native C1QTNF1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
C1QTNF1 is annotated as secreted, so native C1QTNF1 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label C1QTNF1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...